Immuneering Corp (IMRX)
1.54
-0.03
(-1.91%)
USD |
NASDAQ |
May 16, 16:00
1.54
0.00 (0.00%)
After-Hours: 20:00
Immuneering Cash and Short Term Investments (Quarterly): 71.28M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 71.28M |
| December 31, 2023 | 85.67M |
| September 30, 2023 | 97.24M |
| June 30, 2023 | 108.99M |
| March 31, 2023 | 91.54M |
| December 31, 2022 | 105.52M |
| September 30, 2022 | 117.20M |
| Date | Value |
|---|---|
| June 30, 2022 | 128.10M |
| March 31, 2022 | 137.77M |
| December 31, 2021 | 149.20M |
| September 30, 2021 | 149.48M |
| June 30, 2021 | 50.25M |
| March 31, 2021 | 30.93M |
| December 31, 2020 | 37.09M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
30.93M
Minimum
Mar 2021
149.48M
Maximum
Sep 2021
97.16M
Average
101.38M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Geron Corp | 443.05M |
| SELLAS Life Sciences Group Inc | 2.53M |
| Elicio Therapeutics Inc | 12.89M |
| Vistagen Therapeutics Inc | 126.56M |
| ADMA Biologics Inc | 45.32M |